These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 23924270)

  • 1. Zolpidem induces paradoxical metabolic and vascular changes in a patient with PVS.
    Rodriguez-Rojas R; Machado C; Alvarez L; Carballo M; Estevez M; Perez-Nellar J; Pavon N; Chinchilla M; Carrick FR; DeFina P
    Brain Inj; 2013; 27(11):1320-9. PubMed ID: 23924270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient awakening from vegetative state: is high-dose zolpidem more effective?
    Calabrò RS; Aricò I; De Salvo S; Conti-Nibali V; Bramanti P
    Psychiatry Clin Neurosci; 2015 Feb; 69(2):122-3. PubMed ID: 24965312
    [No Abstract]   [Full Text] [Related]  

  • 3. Zolpidem arousing effect in persistent vegetative state patients: autonomic, EEG and behavioral assessment.
    Machado C; Estévez M; Rodríguez R; Pérez-Nellar J; Chinchilla M; DeFina P; Leisman G; Carrick FR; Melillo R; Schiavi A; Gutiérrez J; Carballo M; Machado A; Olivares A; Pérez-Cruz N
    Curr Pharm Des; 2014; 20(26):4185-202. PubMed ID: 24025063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug induced arousal from the permanent vegetative state.
    Clauss R; Nel W
    NeuroRehabilitation; 2006; 21(1):23-8. PubMed ID: 16720934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zolpidem reduces the blood oxygen level-dependent signal during visual system stimulation.
    Licata SC; Lowen SB; Trksak GH; Maclean RR; Lukas SE
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1645-52. PubMed ID: 21640782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential benefits of zolpidem in disorders of consciousness.
    Noormandi A; Shahrokhi M; Khalili H
    Expert Rev Clin Pharmacol; 2017 Sep; 10(9):983-992. PubMed ID: 28649875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GABA(A) alpha-1 subunit mediated desynchronization of elevated low frequency oscillations alleviates specific dysfunction in stroke--a case report.
    Hall SD; Yamawaki N; Fisher AE; Clauss RP; Woodhall GL; Stanford IM
    Clin Neurophysiol; 2010 Apr; 121(4):549-55. PubMed ID: 20097125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zolpidem for persistent vegetative state--a placebo-controlled trial in pediatrics.
    Snyman N; Egan JR; London K; Howman-Giles R; Gill D; Gillis J; Scheinberg A
    Neuropediatrics; 2010 Oct; 41(5):223-7. PubMed ID: 21210338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zolpidem arouses patients in vegetative state after brain injury: quantitative evaluation and indications.
    Du B; Shan A; Zhang Y; Zhong X; Chen D; Cai K
    Am J Med Sci; 2014 Mar; 347(3):178-82. PubMed ID: 23462249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zolpidem in a minimally conscious state.
    Singh R; McDonald C; Dawson K; Lewis S; Pringle AM; Smith S; Pentland B
    Brain Inj; 2008 Jan; 22(1):103-6. PubMed ID: 18183514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hypnotic zolpidem increases the synchrony of BOLD signal fluctuations in widespread brain networks during a resting paradigm.
    Licata SC; Nickerson LD; Lowen SB; Trksak GH; Maclean RR; Lukas SE
    Neuroimage; 2013 Apr; 70():211-22. PubMed ID: 23296183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved Arousal and Motor Function Using Zolpidem in a Patient With Space-Occupying Intracranial Lesions: A Case Report.
    Bomalaski MN; Smith SR
    PM R; 2017 Aug; 9(8):831-833. PubMed ID: 28093373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EEG-vigilance and BOLD effect during simultaneous EEG/fMRI measurement.
    Olbrich S; Mulert C; Karch S; Trenner M; Leicht G; Pogarell O; Hegerl U
    Neuroimage; 2009 Apr; 45(2):319-32. PubMed ID: 19110062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient improvement of poststroke apathy with zolpidem: a single-case, placebo-controlled double-blind study.
    Autret K; Arnould A; Mathieu S; Azouvi P
    BMJ Case Rep; 2013 Feb; 2013():. PubMed ID: 23396925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of the evidence of zolpidem efficacy in neurological disability after brain damage due to stroke, trauma and hypoxia: A justification of further clinical trials.
    Sutton JA; Clauss RP
    Brain Inj; 2017; 31(8):1019-1027. PubMed ID: 28534652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of clinically significant responses to zolpidem among patients with disorders of consciousness: a preliminary placebo controlled trial.
    Whyte J; Myers R
    Am J Phys Med Rehabil; 2009 May; 88(5):410-8. PubMed ID: 19620954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic interaction between zolpidem and carbamazepine in healthy volunteers.
    Vlase L; Popa A; Neag M; Muntean D; Bâldea I; Leucuţa SE
    J Clin Pharmacol; 2011 Aug; 51(8):1233-6. PubMed ID: 21098143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zolpidem efficacy and safety in disorders of consciousness.
    Machado C; Estévez M; Rodriguez-Rojas R
    Brain Inj; 2018; 32(4):530-531. PubMed ID: 29393689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood-brain barrier integrity in a zolpidem-responder patient.
    Nyakale NE; Clauss RP; Nel HW; Sathekge MM
    S Afr Med J; 2012 Jul; 102(10):790-1. PubMed ID: 23034205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conventional and power spectrum analysis of the effects of zolpidem on sleep EEG in patients with chronic primary insomnia.
    Monti JM; Alvariño F; Monti D
    Sleep; 2000 Dec; 23(8):1075-84. PubMed ID: 11145322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.